AL001, Lithium carbonate — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL
Phase 1/2 · Bipolar I Disorder |
ALZN Alzamend Neuro, Inc. | AL001, Lithium carbonate |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|